3-121586055-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001012659.2(ARGFX):āc.403A>Cā(p.Lys135Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,587,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001012659.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARGFX | NM_001012659.2 | c.403A>C | p.Lys135Gln | missense_variant | 5/5 | ENST00000334384.5 | NP_001012677.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARGFX | ENST00000334384.5 | c.403A>C | p.Lys135Gln | missense_variant | 5/5 | 3 | NM_001012659.2 | ENSP00000335578 | P1 | |
ARGFX | ENST00000651603.1 | c.403A>C | p.Lys135Gln | missense_variant | 4/4 | ENSP00000498601 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000311 AC: 7AN: 225352Hom.: 0 AF XY: 0.0000412 AC XY: 5AN XY: 121242
GnomAD4 exome AF: 0.0000446 AC: 64AN: 1435674Hom.: 0 Cov.: 30 AF XY: 0.0000449 AC XY: 32AN XY: 712510
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2022 | The c.403A>C (p.K135Q) alteration is located in exon 5 (coding exon 4) of the ARGFX gene. This alteration results from a A to C substitution at nucleotide position 403, causing the lysine (K) at amino acid position 135 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at